Login / Signup

Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials.

Niccolò LombardiGiada CrescioliAlessandra BettiolClaudia RavaldiNiccolò Lombardi
Published in: Pharmacoepidemiology and drug safety (2019)
Keyphrases
  • clinical trial
  • open label
  • pulmonary hypertension
  • phase ii
  • study protocol
  • combination therapy